143 related articles for article (PubMed ID: 19392772)
1. In vitro platelet function of platelet concentrates prepared using three different apheresis devices determined by impedance and optical aggregometry.
Jilma-Stohlawetz P; Eichelberger B; Horvath M; Jilma B; Panzer S
Transfusion; 2009 Aug; 49(8):1564-8. PubMed ID: 19392772
[TBL] [Abstract][Full Text] [Related]
2. Limiting and detecting bacterial contamination of apheresis platelets: inlet-line diversion and increased culture volume improve component safety.
Eder AF; Kennedy JM; Dy BA; Notari EP; Skeate R; Bachowski G; Mair DC; Webb JS; Wagner SJ; Dodd RY; Benjamin RJ;
Transfusion; 2009 Aug; 49(8):1554-63. PubMed ID: 19413735
[TBL] [Abstract][Full Text] [Related]
3. The effect of plasma removal from apheresis platelet concentrates on platelet function.
Jilma-Stohlawetz P; Eichelberger B; List J; Jilma B; Panzer S; Leitner G
Vox Sang; 2012 Apr; 102(3):258-60. PubMed ID: 21923859
[TBL] [Abstract][Full Text] [Related]
4. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
[TBL] [Abstract][Full Text] [Related]
5. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.
Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM
Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363
[TBL] [Abstract][Full Text] [Related]
6. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
Glas M; Bauer JV; Eichler H; Volk T
Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
Moog R; Fröhlich A; Mayaudon V; Lin L
J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
[TBL] [Abstract][Full Text] [Related]
8. Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry.
Rahe-Meyer N; Winterhalter M; Boden A; Froemke C; Piepenbrock S; Calatzis A; Solomon C
Acta Anaesthesiol Scand; 2009 Feb; 53(2):168-75. PubMed ID: 19175576
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Impact-R for monitoring the platelet storage lesion.
Albanyan AM; Murphy MF; Harrison P
Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry.
Femia EA; Pugliano M; Podda G; Cattaneo M
Platelets; 2012; 23(1):7-10. PubMed ID: 21770862
[TBL] [Abstract][Full Text] [Related]
11. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
[TBL] [Abstract][Full Text] [Related]
12. [Study of the platelet concentrate obtained with the MCS cell separator of the Society of Haemonetics].
Schooneman F
Ann Med Interne (Paris); 1994; 145(5):345-9. PubMed ID: 7985946
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of platelet concentrates obtained using blood cell separators with continuous flow: CS-3000 and Cobe-Spectra].
Dzieciatkowska A; Fusiewicz M; Lachert E; Ziemba-Zółtowska B; Sabliński J
Acta Haematol Pol; 1994; 25(2):129-34. PubMed ID: 8067183
[TBL] [Abstract][Full Text] [Related]
14. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
Pietersz RN
Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
[TBL] [Abstract][Full Text] [Related]
15. Function of platelets in apheresis platelet concentrates and in patient blood after transfusion as assessed by Impact-R.
Horvath M; Eichelberger B; Koren D; Böhm A; Ay C; Jilma B; Panzer S; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1036-42. PubMed ID: 20051058
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets.
Keklik M; Keklik E; Korkmaz S; Aygun B; Arik F; Kilic O; Sarikoc M
Transfus Apher Sci; 2015 Dec; 53(3):396-8. PubMed ID: 26283175
[TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of platelet concentrates with multiple electrode aggregometry.
Shams Hakimi C; Hesse C; Wallén H; Boulund F; Grahn A; Jeppsson A
Platelets; 2015; 26(2):132-7. PubMed ID: 24999542
[TBL] [Abstract][Full Text] [Related]
18. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of platelet concentrates, with particular reference to Autopheresis C Plateletcell: correlation between dMPV and other tests for platelet function.
Vickers MV; Ip AH; Cutts M; Tandy NP; Seghatchian MJ
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):361-6. PubMed ID: 1909905
[TBL] [Abstract][Full Text] [Related]
20. Impact of tobacco smoking on platelet function in apheresis products in vitro.
Scheinichen D; Heuft HG; Renken C; Jüttner B; Jaeger K; Schürholz T; Blasczyk R; Piepenbrock S; Elsner HA
Vox Sang; 2004 May; 86(4):252-6. PubMed ID: 15144530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
